|
ZNF599 expression based on
|
| Comparison | Statistical significance |
| Normal-vs-Primary | 2.3866464360367E-12 |
|
Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
1.91510030056463E-10 |
| Normal-vs-Stage2 |
1.81820000000332E-06 |
| Normal-vs-Stage3 |
1.88350002261473E-10 |
| Normal-vs-Stage4 |
1.38800004823025E-09 |
| Stage1-vs-Stage2 |
9.692200E-01 |
| Stage1-vs-Stage3 |
5.597900E-02 |
| Stage1-vs-Stage4 |
3.658300E-02 |
| Stage2-vs-Stage3 |
2.170600E-01 |
| Stage2-vs-Stage4 |
9.609500E-02 |
| Stage3-vs-Stage4 |
6.026200E-01 |
|
|
Note
Patient race information is not available for 92 samples and one samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
6.27276008913213E-14 |
| Normal-vs-AfricanAmerican |
3.921900E-03 |
| Normal-vs-Asian |
5.69019999999698E-05 |
| Caucasian-vs-AfricanAmerican |
1.282010E-01 |
| Caucasian-vs-Asian |
7.711900E-02 |
| AfricanAmerican-vs-Asian |
8.553200E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
1.10700000277575E-08 |
| Normal-vs-Female |
2.45725662040286E-12 |
| Male-vs-Female |
5.086800E-01 |
|
|
Note
Seventeen samples from patient below 21 years not considered in above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
5.71760416789857E-11 |
| Normal-vs-Age(41-60Yrs) |
3.33340000047144E-09 |
| Normal-vs-Age(61-80Yrs) |
7.62979679436171E-11 |
| Normal-vs-Age(81-100Yrs) |
3.370400E-02 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
9.570000E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
2.494600E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
8.377600E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
2.778000E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
7.782600E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
6.533400E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Classical-VS-Tall |
1.2058998244413E-10 |
| Classical-VS-Follicular |
3.856000E-01 |
| Classical-VS-Other |
6.875600E-01 |
| Classical-VS-Normal |
6.22289997309622E-11 |
| Tall-VS-Follicular |
2.30709995552303E-09 |
| Tall-VS-Other |
1.656450E-02 |
| Tall-VS-Normal |
3.33066907387547E-16 |
| Follicular-VS-Other |
9.221000E-01 |
| Follicular-VS-Normal |
2.76509999996843E-06 |
| Other-VS-Normal |
4.656500E-02 |
|
|
Note
Cancer in nearby lymph nodes cannot be measured (NX) in 50 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
3.29079999916715E-08 |
| Normal-vs-N1 |
1.15430000002803E-08 |
| N0-vs-N1 |
1.326640E-01 |
|
|
